BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18040766)

  • 1. Inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region.
    Zhao X; Schwartz S
    Virus Genes; 2008 Feb; 36(1):45-53. PubMed ID: 18040766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers.
    Zhao X; Fay J; Lambkin H; Schwartz S
    Virology; 2007 Dec; 369(2):351-63. PubMed ID: 17869320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.
    Zhao X; Rush M; Schwartz S
    J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.
    Li X; Johansson C; Glahder J; Mossberg AK; Schwartz S
    Nucleic Acids Res; 2013 Dec; 41(22):10488-508. PubMed ID: 24013563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
    Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific interaction between hnRNP H and HPV16 L1 proteins: implications for late gene auto-regulation enabling rapid viral capsid protein production.
    Zheng ZZ; Sun YY; Zhao M; Huang H; Zhang J; Xia NS; Miao J; Zhao Q
    Biochem Biophys Res Commun; 2013 Jan; 430(3):1047-53. PubMed ID: 23261416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.
    Dhanjal S; Kajitani N; Glahder J; Mossberg AK; Johansson C; Schwartz S
    J Biol Chem; 2015 May; 290(21):13354-71. PubMed ID: 25878250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.
    Ajiro M; Tang S; Doorbar J; Zheng ZM
    J Virol; 2016 Oct; 90(20):9138-52. PubMed ID: 27489271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632.
    Somberg M; Zhao X; Fröhlich M; Evander M; Schwartz S
    J Virol; 2008 Apr; 82(7):3665-78. PubMed ID: 18216120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
    Damgaard CK; Tange TO; Kjems J
    RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements.
    Black AC; Luo J; Watanabe C; Chun S; Bakker A; Fraser JK; Morgan JP; Rosenblatt JD
    J Virol; 1995 Nov; 69(11):6852-8. PubMed ID: 7474099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a novel reporter assay for human papillomavirus type 16 late gene expression.
    Orrù B; Cunniffe C; Ryan F; Schwartz S
    J Virol Methods; 2012 Aug; 183(2):106-16. PubMed ID: 22484615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
    Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
    J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry.
    Hindmarsh PL; Laimins LA
    Virol J; 2007 Feb; 4():19. PubMed ID: 17324266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner.
    Kajitani N; Glahder J; Wu C; Yu H; Nilsson K; Schwartz S
    Nucleic Acids Res; 2017 Sep; 45(16):9654-9678. PubMed ID: 28934469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.
    Oberg D; Fay J; Lambkin H; Schwartz S
    J Virol; 2005 Jul; 79(14):9254-69. PubMed ID: 15994820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.
    Mayeda A; Krainer AR
    Cell; 1992 Jan; 68(2):365-75. PubMed ID: 1531115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation.
    Siddiqa A; Léon KC; James CD; Bhatti MF; Roberts S; Parish JL
    J Gen Virol; 2015 Aug; 96(8):2274-2285. PubMed ID: 25911730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.